Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15331856 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
Condition: Alzheimer's Disease
Intervention: Drug: VP4896

Study has passed its completion date and status has not been verified in more than two years.